Hikma Sees Field For Generic Of Advair Narrow As It Enrols Study

 
• By Aidan Fry

The challenges of developing a US generic of GlaxoSmithKline’s Advair Diskus fluticasone/salmeterol asthma blockbuster are thinning the field and improving the commercial prospects for those that succeed, Hikma believes.

Horses
High hurdles to developing a US generic of GSK's Advair Diskus inhaler are seeing several companies falling away, Hikma believes • Source: Shutterstock

More from Generics

More from Products